Identification of novel epithelial ovarian cancer loci in women of African ancestry

Women of African ancestry have lower incidence of epithelial ovarian cancer (EOC) yet worse survival compared to women of European ancestry. We conducted a genome‐wide association study in African ancestry women with 755 EOC cases, including 537 high‐grade serous ovarian carcinomas (HGSOC) and 1,235 controls. We identified four novel loci with suggestive evidence of association with EOC (p < 1 × 10−6), including rs4525119 (intronic to AKR1C3), rs7643459 (intronic to LOC101927394), rs4286604 (12 kb 3′ of UGT2A2) and rs142091544 (5 kb 5′ of WWC1). For HGSOC, we identified six loci with suggestive evidence of association including rs37792 (132 kb 5′ of follistatin [FST]), rs57403204 (81 kb 3′ of MAGEC1), rs79079890 (LOC105376360 intronic), rs66459581 (5 kb 5′ of PRPSAP1), rs116046250 (GABRG3 intronic) and rs192876988 (32 kb 3′ of GK2). Among the identified variants, two are near genes known to regulate hormones and diseases of the ovary (AKR1C3 and FST), and two are linked to cancer (AKR1C3 and MAGEC1). In follow‐up studies of the 10 identified variants, the GK2 region SNP, rs192876988, showed an inverse association with EOC in European ancestry women (p = 0.002), increased risk of ER positive breast cancer in African ancestry women (p = 0.027) and decreased expression of GK2 in HGSOC tissue from African ancestry women (p = 0.004). A European ancestry‐derived polygenic risk score showed positive associations with EOC and HGSOC in women of African ancestry suggesting shared genetic architecture. Our investigation presents evidence of variants for EOC shared among European and African ancestry women and identifies novel EOC risk loci in women of African ancestry.

[1]  Jennifer A. Doherty,et al.  Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. , 2019, Gynecologic oncology.

[2]  E. Funkhouser,et al.  Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case–control study , 2018, Cancer Causes & Control.

[3]  O. Olopade,et al.  Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry , 2018, Molecular carcinogenesis.

[4]  A. Jemal,et al.  Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[5]  S. Rayala,et al.  KIBRA; a novel biomarker predicting recurrence free survival of breast cancer patients receiving adjuvant therapy , 2018, BMC Cancer.

[6]  Amber L. Couzens,et al.  KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer , 2018, Cell reports.

[7]  Qianqian Zhu,et al.  Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study , 2018, PLoS genetics.

[8]  Liang Zhang,et al.  Association of KIBRA polymorphism with risk of Alzheimer’s disease: Evidence based on 20 case-control studies , 2018, Neuroscience Letters.

[9]  T. Sellers,et al.  Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[10]  Kconfab Investigators,et al.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer , 2017 .

[11]  Lara E Sucheston-Campbell,et al.  Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[12]  Lara E Sucheston-Campbell,et al.  Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer , 2017, Nature Genetics.

[13]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[14]  James E. Dinulos,et al.  FastPop: a rapid principal component derived method to infer intercontinental ancestry using genetic data , 2016, BMC Bioinformatics.

[15]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[16]  T. Sellers,et al.  A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer , 2015, Oncotarget.

[17]  Vida Kocbek,et al.  Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2α biosynthesis and action in ovarian endometriosis tissue and in model cell lines. , 2015, Chemico-biological interactions.

[18]  Yankai Xia,et al.  Association analysis between the polymorphisms of HSD17B5 and HSD17B6 and risk of polycystic ovary syndrome in Chinese population. , 2015, European journal of endocrinology.

[19]  E. Funkhouser,et al.  A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES) , 2014, BMC Cancer.

[20]  C. Morrison,et al.  Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer , 2014, PloS one.

[21]  D. Wennmann,et al.  KIBRA: In the brain and beyond. , 2014, Cellular signalling.

[22]  Stephen R. Williams,et al.  Using previously genotyped controls in genome-wide association studies (GWAS): application to the Stroke Genetics Network (SiGN) , 2014, Front. Genet..

[23]  Ross M. Fraser,et al.  A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness , 2014, PLoS genetics.

[24]  Brooke L. Fridley,et al.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.

[25]  F. Dudbridge.  Power and Predictive Accuracy of Polygenic Risk Scores , 2013, PLoS genetics.

[26]  C. Carty,et al.  Replication of Breast Cancer GWAS Susceptibility Loci in the Women's Health Initiative African American SHARe Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[27]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[28]  K. Vouk,et al.  Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis. , 2011, Chemico-biological interactions.

[29]  Gary K. Chen,et al.  Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21 , 2011, Nature Genetics.

[30]  Ronald C. Petersen,et al.  Association of common KIBRA variants with episodic memory and AD risk , 2011, Neurobiology of Aging.

[31]  Chunyu Liu,et al.  Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods , 2011, PloS one.

[32]  M. Huentelman,et al.  Identification of a common variant affecting human episodic memory performance using a pooled genome-wide association approach: a case study of disease gene identification. , 2011, Methods in molecular biology.

[33]  Richard J. Caselli,et al.  Evidence for an association between KIBRA and late-onset Alzheimer's disease , 2010, Neurobiology of Aging.

[34]  Yao-Tseng Chen,et al.  Cancer/testis (CT) antigens: Potential targets for immunotherapy , 2009, Cancer science.

[35]  B. Husen,et al.  Disturbed estrogen and progesterone action in ovarian endometriosis , 2009, Molecular and Cellular Endocrinology.

[36]  S. Bhattacharya,et al.  Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. , 2009, Reproductive biomedicine online.

[37]  Amy Lee,et al.  Cav1 L‐type Ca2+ channel signaling complexes in neurons , 2008, Journal of neurochemistry.

[38]  Shufeng Zhou,et al.  Structure, function and polymorphism of human cytosolic sulfotransferases. , 2008, Current drug metabolism.

[39]  Trevor M Penning,et al.  Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms. , 2007, Archives of biochemistry and biophysics.

[40]  Jon Wakefield,et al.  A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.

[41]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[42]  G. Watts,et al.  Polymorphism of the follistatin gene in polycystic ovary syndrome. , 2007, Molecular human reproduction.

[43]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[44]  J. Resau,et al.  The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. , 2005, Cancer cell.

[45]  J. Morrison,et al.  Regulation of ovarian function by the TGF-beta superfamily and follistatin. , 2003, Reproduction.

[46]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[47]  M. Bertrand,et al.  An overview of the MAGE gene family with the identification of all human members of the family. , 2001, Cancer research.

[48]  J. Dallongeville,et al.  Glycerol kinase deficiency: Evidence for complexity in a single gene disorder , 2001, Human Genetics.

[49]  Michael E. Burczynski,et al.  Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .

[50]  N. Palackal,et al.  Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. , 2000, The Biochemical journal.

[51]  M. Urbanek,et al.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Risch.  Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.